SFRE diminished the expression of PD-L1 and CX3CR1 as shown in Figure 9C, which indicates the potential of SFRE ameliorating the expression of biomarkers that promote immune evasion of the lung cancer cells. The gene discussed is CX3CR1; the disease is lung carcinoma.